Sleep gummies pair these two so often that most people assume they do the same job. They don’t — and the guidelines are blunter about melatonin than the shelf is.
The short answer
Neither is recommended for insomnia. Melatonin is for timing.
The American Academy of Sleep Medicine’s 2017 guideline suggests clinicians not use melatonin for sleep onset or sleep maintenance insomnia — weak recommendation, very low quality evidence. Its 2015 circadian guideline does back strategically timed melatonin for delayed sleep-wake phase disorder. CBD at 150 mg nightly matched placebo.
Two different jobs
| Factor | Melatonin | CBD |
|---|---|---|
| What it is | A hormone; a darkness signal | A hemp cannabinoid; not sedating |
| The problem it fits | Timing — jet lag, shift work, a clock running late | Wind-down — stress and rumination |
| What guidelines say | AASM suggests against it for insomnia; backed for delayed sleep-wake phase disorder | No approved product; the FDA says selling CBD as a dietary supplement is illegal |
| Doses in research and on labels | 0.5–3 mg, 30–60 minutes before bed | 25–300 mg+ per evening in trials; 25–50 mg is the common beginner range |
| Onset | 30–60 minutes | 15–30 minutes under the tongue; up to 2 hours for a gummy |
| Next day | Grogginess at higher doses | Grogginess and digestive upset, dose-dependent |
| Drug interactions | Fewer, but real | Competes for liver enzymes clearing blood thinners, antidepressants, seizure drugs |
Check what’s in the jar. A 2023 JAMA analysis of 25 melatonin gummies sold in the US found 22 (88%) inaccurately labelled — actual melatonin ran 74–347% of the declared amount, and one contained none. The five also listing CBD were closer, 104–118%.
What the trials show
Melatonin. The NIH’s complementary health centre says the chronic-insomnia evidence isn’t strong enough to recommend it, and points to cognitive behavioural therapy. Jet lag is where it beat placebo; shift work gained roughly 24 minutes of daytime sleep.
CBD. A 2022 systematic review found most studies reported some improvement — small samples, mostly self-reported. A 2024 pilot trial of 150 mg nightly matched placebo on insomnia severity, sleep latency and time awake at night; objective sleep efficiency was slightly better after two weeks.
A crossover trial of 300 mg CBD plus eight terpenes raised combined deep and REM sleep by 1.3% of nightly sleep time (P = .03) — a combination formula, not CBD alone. The full record is split, not settled.
Who should not use either
- Anyone on prescription medication — blood thinners, antidepressants and seizure drugs especially. Ask your provider.
- Pregnant or nursing. Neither.
- Anyone subject to drug testing. Melatonin is fine; full-spectrum CBD carries trace THC (≤0.3%) that can occasionally register.
- Children. NCCIH cites ~11,000 US emergency visits, 2019–2022, for unsupervised melatonin ingestion by under-fives.
- Heavy snoring or gasping in sleep — that suggests apnea, which a supplement can mask.
- A sleep problem that has lasted weeks. That’s a provider, not a gummy.
Which one first?
Body clock in the wrong time zone — melatonin, small and timed. A mind that won’t switch off — CBD, with modest expectations. If you can’t tell which, that’s itself the finding.
Do the free things first. Sleep hygiene mistakes and falling asleep faster move more minutes than either. If you still want to test CBD, our dosage guide sets up the trial.
Sources
- Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults — American Academy of Sleep Medicine, J Clin Sleep Med 2017;13:307–349.
- Clinical Practice Guideline for Intrinsic Circadian Rhythm Sleep-Wake Disorders — An Update for 2015 — American Academy of Sleep Medicine, J Clin Sleep Med 2015;11(10):1199–1236.
- Melatonin: What You Need To Know — National Center for Complementary and Integrative Health, NIH.
- Quantity of Melatonin and CBD in Melatonin Gummies Sold in the US — JAMA, 2023;329(16):1401–1402.
- Use of Cannabidiol in the Management of Insomnia: A Systematic Review — Cannabis and Cannabinoid Research, 2022.
- Cannabidiol for moderate–severe insomnia: a randomized controlled pilot trial of 150 mg of nightly dosing — Journal of Clinical Sleep Medicine, 2024;20(5):753–763.
- Effects of a cannabidiol/terpene formulation on sleep in individuals with insomnia — Journal of Clinical Sleep Medicine, 2025;21(1):69–80 (published online 2024).
How we make money. Some links on this page are affiliate links. If you buy through one, we may earn a commission at no extra cost to you. It does not change what we write — see our affiliate disclosure.
These statements have not been evaluated by the Food and Drug Administration. CBD products are not intended to diagnose, treat, cure or prevent any disease. Serene Leaf does not physically test products; our assessments are based on published research, third-party lab reports and publicly available product information.
This article is information, not medical advice. Talk to a qualified healthcare provider before starting any supplement — especially if you are pregnant, nursing, taking medication or managing a diagnosed condition. 21+ only.